|
32
|
170
|
2bt8A |
Structure of the c-terminal receptor-binding domain of avian reovirus fibre sigmac, space group p6322. |
|
24
|
140
|
2bo2A |
Egf domains 1,2,5 of human emr2, a 7-tm immune system molecule, in complex with calcium. |
|
12
|
52
|
2bqwA |
Crystal structure of factor xa in complex with compound 45 |
|
18
|
94
|
2b7dL |
Factor viia inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in a baboon thrombosis model |
|
12
|
51
|
2bokL |
Factor xa - cation |
|
11
|
52
|
2bq7A |
Crystal structure of factor xa in complex with 43 |
|
11
|
53
|
2bohA |
Crystal structure of factor xa in complex with compound "1" |
|
192
|
553
|
2aylA |
2.0 angstrom crystal structure of manganese protoporphyrin ix-reconstituted ovine prostaglandin h2 synthase-1 complexed with flurbiprofen |
|
2
|
40
|
2adxA |
Fifth egf-like domain of thrombomodulin (tmegf5), nmr, minimized average structure |
|
2
|
44
|
1zaqA |
Fourth egf-like domain of thrombomodulin, nmr, 12 structures |
|
4
|
87
|
1z6cA |
Solution structure of an egf pair (egf34) from vitamin k-dependent protein s |
|
165
|
621
|
1yo8A |
Structure of the c-terminal domain of human thrombospondin-2 |
|
13
|
52
|
1z6eL |
Factor xa in complex with the inhibitor 1-(3'-amino-1,2-benzisoxazol-5'-yl)-n-(4-(2'-((dimethylamino)methyl)-1h-imidazol-1-yl)-2-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (razaxaban; dpc906; bms-561389) |
|
10
|
53
|
1ygcL |
Short factor viia with a small molecule inhibitor |
|
5
|
50
|
1yugA |
Type alpha transforming growth factor, nmr, 15 models after ecepp/3 energy minimization |
|
16
|
120
|
1yukB |
The crystal structure of the psi/hybrid domain/ i-egf1 segment from the human integrin beta2 at 1.8 resolution |
|
2
|
50
|
1yufA |
Type alpha transforming growth factor, nmr, 16 models without energy minimization |
|
17
|
91
|
1xkbA |
Factor xa complexed with a synthetic inhibitor fx-2212a,(2s)-(3'-amidino-3-biphenylyl)-5-(4-pyridylamino)pentanoic acid |
|
14
|
91
|
1xkaL |
Factor xa complexed with a synthetic inhibitor fx-2212a,(2s)-(3'-amidino-3-biphenylyl)-5-(4-pyridylamino)pentanoic acid |
|
17
|
97
|
1x7aL |
Porcine factor ixa complexed to 1-{3-[amino(imino)methyl]phenyl}-n-[4-(1h-benzimidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide |
|
5
|
83
|
1xfeA |
Solution structure of the la7-egfa pair from the ldl receptor |
|
4
|
86
|
1whfA |
Coagulation factor, nmr, 15 structures |
|
4
|
86
|
1wheA |
Coagulation factor, nmr, 20 structures |
|
11
|
54
|
1wu1B |
Factor xa in complex with the inhibitor 4-[(5-chloroindol-2-yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl) pyrimidin-2-yl]carbonyl]piperazine |
|
8
|
41
|
1xdtR |
Complex of diphtheria toxin and heparin-binding epidermal growth factor |
|
11
|
55
|
1w7xL |
Factor7 - 413 complex |
|
11
|
55
|
1w8bL |
Factor7 - 413 complex |
|
12
|
52
|
1v3xB |
Factor xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2-carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine |
|
29
|
162
|
1uzjA |
Integrin binding cbegf22-tb4-cbegf33 fragment of human fibrillin-1, holo form. |
|
9
|
109
|
1v1iA |
Adenovirus fibre shaft sequence n-terminally fused to the bacteriophage t4 fibritin foldon trimerisation motif with a long linker |
|
10
|
130
|
1urkA |
Solution structure of the amino terminal fragment of urokinase-type plasminogen activator |
|
30
|
162
|
1uzkA |
Integrin binding cbegf22-tb4-cbegf33 fragment of human fibrillin-1, ca bound to cbegf23 domain only |
|
9
|
103
|
1v1hA |
Adenovirus fibre shaft sequence n-terminally fused to the bacteriophage t4 fibritin foldon trimerisation motif with a short linker |
|
30
|
162
|
1uzqA |
Integrin binding cbegf22-tb4-cbegf33 fragment of human fibrillin-1, apo form cbegf23 domain only. |
|
30
|
162
|
1uzpA |
Integrin binding cbegf22-tb4-cbegf33 fragment of human fibrillin-1, sm bound form cbegf23 domain only. |
|
164
|
553
|
1u67A |
Crystal structure of arachidonic acid bound to a mutant of prostagladin h synthase-1 that forms predominantly 11-hpete. |
|
119
|
690
|
1u8cB |
A novel adaptation of the integrin psi domain revealed from its crystal structure |
|
9
|
116
|
1tozA |
Nmr structure of the human notch-1 ligand binding region |
|
3
|
58
|
1tleA |
Le (laminin-type egf-like) module giii4 in solution at ph 3.5 and 290 k, nmr, 14 structures |
|
9
|
91
|
1tpgA |
F1-g module pair residues 1-91 (c83s) of tissue-type plasminogen activator (t-pa) (nmr, 298k, ph2.95, representative structure) |
|
33
|
167
|
1szbA |
Crystal structure of the human mbl-associated protein 19 (map19) |
|
9
|
57
|
1rfnB |
Human coagulation factor ixa in complex with p-amino benzamidine |
|
15
|
96
|
1qfkL |
Structure of human factor viia and its implications for the triggering of blood coagulation |
|
197
|
553
|
1q4gA |
2.0 angstrom crystal structure of ovine prostaglandin h2 synthase-1, in complex with alpha-methyl-4-biphenylacetic acid |
|
53
|
264
|
1qiuA |
A triple beta-spiral in the adenovirus fibre shaft reveals a new structural motif for biological fibres |
|
193
|
551
|
1pgeA |
Prostaglandin h2 synthase-1 complexed with p-(2'-iodo-5'-thenoyl)hydrotropic acid (iodosuprofen) |
|
185
|
554
|
1prhA |
The x-ray crystal structure of the membrane protein prostaglandin h2 synthase-1 |
|
183
|
551
|
1pthA |
The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin h2 synthase |
|
196
|
552
|
1pxxA |
Crystal structure of diclofenac bound to the cyclooxygenase active site of cox-2 |
|
15
|
136
|
1p0sL |
Crystal structure of blood coagulation factor xa in complex with ecotin m84r |
